Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced its ...

Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. | SAN FRANCISCO—Bristol Myers Squibb is ...

WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...

Belpointe PREP, LLC ('Belpointe OZ,” 'we,” 'us,” 'our” or the 'Company”) (NYSE American: OZ), a publicly traded qualified opportunity fund, announced today that the Company entered into an agreement ...

Colorado Buffaloes face defining season under Deion Sanders as transfer questions mount originally appeared on The Sporting ...

Univest Securities, LLC acted as the sole placement agent.

STATEN ISLAND, N.Y.— Staten Island is home to world-class pizzerias, green spaces, and historic sites, and over the past ...

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program ...

Last year delivered doses of drama and excitement in the space business, with a record number of launches, breathtaking ...

Delcy Rodríguez, a guerrilla’s daughter, started out as a provocateur. She pivoted to revive a ravaged economy, making her ...

As Finance Minister Nirmala Sitharaman prepares to present her ninth Budget, expectations centre on a consumption-led growth ...